Expression of CYR61 in human lung cancer tissues and its clinical significance
- Author:
Ling-Ling CUI
1
Author Information
1. College of Public Health
- Publication Type:Journal Article
- Keywords:
Cyr61;
Gene;
Immunohistochemistry;
Lung neoplasms;
Real-time fluorogenetic quantifative PCR
- From:
Tumor
2007;27(4):286-289
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the biological functions of the Cyr61 gene in human lung carcinomas. Methods: The Cyr61 expression levels in the cancerous and peri-cancerous tissues of 60 lung cancer patients were measured by real-time polymerase chain reaction (PCR). Results: The expression of Cyr61 gene was down-regulated in 80% (48/60) primary lung cancer patients compared with the matched pericancerous tissues. The result was consistent with the immunohistochemical staining. Statistical analysis revealed that the difference between expression of cancerous tissues and the matched peri-cancerous tissues was significant [(2.742 ± 4.165) vs (4.933 ± 3.349), t = -5.112, P=0.000]. Furthermore, the clinical variables including tumor grade, tumor metastasis, tumor pathological classification, smoking, and family history influenced the level of Cyr61 expression (P<0.05). Conclusion: Cyr61 may play a key role in the progression of lung carcinoma and its protein might serve as an important target for the therapeutic intervention in clinic.
